Stocklytics Platform
Asset logo for symbol SLNO
Soleno Therapeutics
SLNO55
$42.54arrow_drop_down1.39%-$0.60
Asset logo for symbol SLNO
SLNO55

$42.54

arrow_drop_down1.39%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

Soleno Therapeutics (SLNO) Stocklytics Forecast

Soleno Therapeutics Inc (SLNO) is a biopharmaceutical company focused on developing and commercializing novel therapeutics for the treatment of rare diseases. With a strong pipeline of innovative drug candidates, Soleno Therapeutics is poised for significant growth in the coming years. The company's stock price has shown promising performance in recent times, and analysts have provided positive forecasts for its future value.
According to AI price prediction models, Soleno Therapeutics Inc (SLNO) has the potential to experience substantial growth in the next few years. Machine learning algorithms analyze various data points, such as historical stock prices, market trends, and company financials, to forecast future performance. These predictions indicate that SLNO stock could reach new highs by 2023, making it an attractive investment opportunity.
add Soleno Therapeutics to watchlist

Keep an eye on Soleno Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Soleno Therapeutics (SLNO) stock?

Analysts have set a target price of $34.6 for Soleno Therapeutics (SLNO), based on forecasts from 10 analysts. The predicted price range extends from a high of $93 to a low of $8. This represents a potential increase of up to 118.62% and a decrease of -81.19% from the current price of $42.54. These forecasts are as of 2018 Jun 22.
help

What are the analyst ratings for Soleno Therapeutics (SLNO) stock?

The analyst ratings for Soleno Therapeutics (SLNO) are distributed as follows: 8 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Soleno Therapeutics .
help

What is the AI price prediction for Soleno Therapeutics (SLNO) stock?

At present, there is no AI or machine-learning-based price prediction available for Soleno Therapeutics (SLNO) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level